Taher, A. T. Et Al. 2013. Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. AMERICAN JOURNAL OF HEMATOLOGY , vol.88, no.6 , 503-506.

Taher, A. T., Porter, J. B., Viprakasit, V., Kattamis, A., Chuncharunee, S., Sutcharitchan, P., ... Siritanaratkul, N.(2013). Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. AMERICAN JOURNAL OF HEMATOLOGY , vol.88, no.6, 503-506.

Taher, Ali Et Al. "Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients," AMERICAN JOURNAL OF HEMATOLOGY , vol.88, no.6, 503-506, 2013

Taher, Ali T. Et Al. "Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients." AMERICAN JOURNAL OF HEMATOLOGY , vol.88, no.6, pp.503-506, 2013

Taher, A. T. Et Al. (2013) . "Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients." AMERICAN JOURNAL OF HEMATOLOGY , vol.88, no.6, pp.503-506.

@article{article, author={Ali T. Taher Et Al. }, title={Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients}, journal={AMERICAN JOURNAL OF HEMATOLOGY}, year=2013, pages={503-506} }